Predictors of response in patients with active systemic JIA (SJIA) receiving canakinumab: an exploratory analysis of pooled 12-week data

Παρόμοια τεκμήρια

• Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset
  ανά: Ravelli, A, κ.ά.
  Έκδοση: (2014)
• Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
  ανά: Ravelli, A, κ.ά.
  Έκδοση: (2014)
• Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis
  ανά: Quartier, P, κ.ά.
  Έκδοση: (2014)
• Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients
  ανά: Wulffraat, NM, κ.ά.
  Έκδοση: (2014)
• PReS-FINAL-2158: Effect of canakinumab on functional ability and health-related quality of life in systemic juvenile idiopathic arthritis (SJIA) patients
  ανά: Quartier, P, κ.ά.
  Έκδοση: (2013)